Please login to the form below

Not currently logged in
Email:
Password:

Life Sciences Strategy

This page shows the latest Life Sciences Strategy news and features for those working in and with pharma, biotech and healthcare.

UK trumpets life sciences post-Brexit ‘sector deal’

UK trumpets life sciences post-Brexit ‘sector deal’

UK trumpets life sciences post-Brexit ‘ sector deal’. Highlights commitments from GlaxoSmithKline, AstraZeneca and MSD. ... long-term strategic roadmap set out in the life sciences industrial strategy”.

Latest news

  • NICE: We're the institute of 'yes' NICE: We're the institute of 'yes'

    QuintilesIMS' Question Time: The Future of of Pharma and Life Sciences in the UK meeting came just one week after the publication of Sir John Bells' Life Sciences Industrial Strategy report. ... There will be a full report on QuintilesIMS' Question Time

  • UK life sciences sector sets out its post-Brexit growth proposals UK life sciences sector sets out its post-Brexit growth proposals

    The UK life sciences industry has set out a strategy for making the country a ‘world leader’in the sector. ... future.”. The government is expected to issue a formal response to the Life Sciences Industry Strategy later this year.

  • Mixed news for pharma on UK's Accelerated Access Review Mixed news for pharma on UK's Accelerated Access Review

    AAR’s recommendations into reality now relies on a full, positive government response to the review - and an effective life sciences industrial strategy". ... The BioIndustry Association also welcomed the new package, saying it will make the UK "a more

  • Biogen develops quantum computing-based app to speed drug discovery Biogen develops quantum computing-based app to speed drug discovery

    Jeff Elton, managing director, Accenture Strategy, Life Sciences, said: “As quantum computers become more readily available, it will become easier for pharmaceutical companies to identify and develop new medicines for a ... wide range of diseases and

  • Bayer: Post-truth politics severely handicaps innovation Bayer: Post-truth politics severely handicaps innovation

    Earlier this year the UK government unveiled a new industrial strategy, in which life sciences will play a key role, but uncertainty persists when it comes to the future role of

More from news
Approximately 8 fully matching, plus 41 partially matching documents found.

Latest Intelligence

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    While the Life Sciences Sector. Deal resulted in some positive investment announcements, the reality is that GSK and others have already started to invest in operations outside the UK just in ... Sciences Industrial Strategy and the Accelerated Access

  • The challenges of making genomics a reality for patients The challenges of making genomics a reality for patients

    The Life Sciences Industrial Strategy published in the autumn echoes many of these sentiments. ... In particular, it outlines the need for industry to take on bold, far-sighted ambitions in the life science industry with the intention of creating

  • The challenges of making genomics a reality for patients today, not tomorrow The challenges of making genomics a reality for patients today, not tomorrow

    The Life Sciences Industrial Strategy published in the autumn echoes many of these sentiments. ... In particular, it outlines the need for industry to take on bold, far-sighted ambitions in the life science industry with the intention of creating

  • Pulling together Pulling together

    Responding to these at the end of August saw Sir John Bell publish his ambitious Life Sciences Industrial Strategy report, which offers a wide-ranging plan for making the UK a ... Also speaking at the QuintilesIMS’The Future of Pharma and Life Sciences

  • Pushing the accelerator Pushing the accelerator

    New technology requires new culture. The ultimate aim of clinical trials is to provide the public with life-saving or disease-curing drugs as quickly and safely as possible. ... is global vice president of Life Sciences Product Strategy at Oracle.

More from intelligence
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest appointments

  • AZ's Lisa Anson elected president of ABPI AZ's Lisa Anson elected president of ABPI

    She brings further pharmaceutical management experience from California-based Salick Health Care, where she was vice president of strategy, and management consultancy expertise from KPMG. ... Lisa will play a leading role as we negotiate the future of

  • Merck KGaA appoints Isabel De Paoli as communications head Merck KGaA appoints Isabel De Paoli as communications head

    Isabel De Paoli (pictured) is currently head of group strategy at the German life sciences, health and materials company and will officially step into her new role when Huber's tenure ... ends. Until then she will spend her time preparing for her new

  • New health ministers and re-appointments after reshuffle New health ministers and re-appointments after reshuffle

    State for Life Sciences; and David Prior, Parliamentary Under Secretary of State for NHS Productivity (Lords). ... the uptake of new drugs and med tech, and the government's life sciences industrial strategy.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics